Abstract: Background: Reactive oxygen species (ROS) can modulate renal hemodynamics and function both directly, by leading to vasoconstriction, and indirectly, by inducing renal inflammation and tissue growth. The involvement of oxidative-stress in the pathogenesis of renovascular disease (RVD) is increasingly recognized, but the relative contribution of longterm tissue injury to renal dysfunction remains unclear. We hypothesized that functional and structural alterations elicited by oxidative stress in RVD would be more effectively modulated by chronic than by acute antioxidant intervention. Methods: Renal hemodynamics and function were quantified in-vivo in pigs using electron-beam CT at baseline and after vasoactive challenge (Ach and sodium-nitroprusside), after 12 weeks of RVD (simulated by concurrent hypercholesterolemia and renal-artery-stenosis, n=7), RVD acutely infused with the SODmimetic Tempol (RVD+Tempol, n=7), RVD chronically supplemented with antioxidant vitamins C (1 g) and E (100 IU/kg) (RVD+Vitamins, n=7), or controls (normal, n=7). Renal tissue was studied ex-vivo using immunoblotting and immunohistochemistry. Results: Basal renal-blood-flow (RBF) and glomerular-filtration-rate (GFR) were similarly decreased in all RVD groups. Ach-stimulated RBF remained unchanged in RVD, increased in RVD+Tempol, but further increased (similarly to normal) in RVD+Vitamins (p<0.05 vs. RVD). Furthermore, RVD+Vitamins also showed decreased presence of superoxide anion, NAD(P)H-oxidase and nitrotyrosine expression, increased endothelial-nitric-oxide-synthase expression, and attenuated renal fibrosis. Conclusion: Chronic antioxidant intervention in early RVD improved renal hemodynamic responses more effectively than acute intervention, likely due to increased nitricoxide bioavailability and decreased structural injury. These suggest that chronic tissue changes play an important role in renal compromise mediated by oxidative-stress in RVD.
Introduction
Renovascular diseases (RVD) account for over a third of all cases of end-stage renal disease (ESRD)(1). Renal artery stenosis (RAS) (usually due to atherosclerosis) is one of the most common vascular nephropathies, and may activate multiple and parallel mechanisms that lead to a progressive deterioration of renal function and renal tissue injury (7, 8, 40, 47) . We have previously shown that increased oxidative-stress is likely involved in the mechanism of renal injury in RVD (7) (8) (9) . Reactive oxygen species (ROS) can acutely modulate renal microvascular function, induce vasoconstriction (42) and contribute to the enhanced renal vascular tone and sensitivity to other vasoconstrictors, such as angiotensin II and endothelin-1. The superoxide anion can also react with nitric oxide (NO), decreasing its availability and resulting in formation of the pro-oxidant peroxynitrite, and can impair intra-renal vascular and glomerular function (35, 42) . Furthermore, ROS interfere with renal oxygen usage for tubular sodium transport (53) and enhance tubulo-glomerular feedback (36) .
In addition, ROS are involved in multiple pathways that can lead to renal tissue injury, and chronic antioxidant intervention can slow the progression of renal insufficiency (11) , underscoring the role of the oxidative-stress pathway in renal disease (4, 32, 52) .We have previously shown that increased oxidative-stress in a model of early RVD was associated not only with renal functional impairment, but also with increased expression of pro-inflammatory and pro-growth factors that augmented intra-renal inflammation and fibrosis (7, 8) . These chronic structural changes may also impair renal hemodynamics and function (7, 8) . Hence, increased oxidative-stress can interfere with renal function by both acute and chronic mechanisms.
However, the relative contributions of these pathways to renal dysfunction in RVD are yet unclear. Therefore, the current study was designed to investigate the effects of acute and chronic blockade of the oxidative-stress pathway in RVD. We hypothesized that functional and structural alterations elicited by oxidative stress in RVD would be more effectively modulated by chronic than by acute antioxidant intervention. To evaluate this, renal hemodynamics and function were studied in RVD during an acute intra-renal infusion of the SOD-mimetic Tempol, or after chronic supplementation with vitamins C and E. We used electron-beam computed tomography (EBCT), an ultra-fast scanner that provides accurate and noninvasive quantifications of single-kidney volume, regional perfusion, blood flow, glomerular filtration rate (GFR), and segmental tubular function (6) (7) (8) (9) 20 , 24) of the intact RVD kidney in vivo distal to a stenosis.
Moreover, subsequent in vitro studies further characterized the effects of antioxidant intervention on the stenotic kidney.
Methods
The Institutional Animal Care and Use Committee approved all procedures. Twentyeight domestic pigs (55-65kg) were studied after 12 weeks of observation. In twenty-one pigs, a local-irritant coil was placed in the main renal artery at baseline, and induced gradual development of unilateral RAS, as previously described (7, 8, 24) . The degree of RAS was subsequently measured by quantitative renal angiography (7, 24) . A PhysioTel telemetry system (Data Sciences) was implanted at baseline in the left femoral artery, and blood pressure measurements were obtained in all animals. Mean arterial pressure (MAP) was recorded at 5-minute intervals and averaged for each 24-hour period. Levels reported were those obtained for 2 days before each in vivo study (8, 9) . A high-cholesterol diet (2% cholesterol and 15% lard, TD-93296, Harlan-Teklad, Madison, WI) (6-8, 10) was used to simulate early atherosclerosis (RVD, n=7). Seven RVD animals were orally supplemented with daily doses of vitamin C (1000 mg) and E (100 IU/kg)(46) (RVD+Vitamins, n=7), which provides effective blockade of oxidativestress (38, 39, 46 ). An additional group of RVD pigs were acutely infused intra-renally with the SOD mimetic Tempol (RVD+Tempol, n=7, approximately 225 µmol/kg/min) during the in vivo studies, following previous established protocols (43) . The dose was titrated to the maximal dose that did not decrease blood pressure in our model. The remaining seven pigs were fed with a normal diet and used as controls (normal, n=7).
On the day of studies, each animal was anesthetized with intra-muscular telazol (5mg/kg) and xylazine (2 mg/kg), intubated, and mechanically ventilated with room air. Anesthesia was maintained with a mixture of ketamine (0.2 mg/kg/min) and xylazine (0.03 mg/kg/min) in normal saline, administered via an ear vein cannula (0.05 mL/kg/min). Blood samples were collected from the inferior vena cava for measurement of vitamin levels (high-performance liquid chromatography), plasma renin activity (PRA, radioimmunoassay), SOD activity and serum creatinine (spectrophotometry). Under sterile conditions and fluoroscopic guidance, an 8F arterial guide was inserted in the left carotid artery, and then advanced and positioned in the descending aorta. Through it, a low-profile tracker catheter (21) was positioned in the midsection of the stenotic main renal artery, proximal to the stenosis. Tempol infusion was initiated in RVD+Tempol animals 15 minutes before the beginning of the EBCT studies, and because of its short half-life(48) was continuously infused throughout the study. In vivo EBCT flow studies were then performed as previously detailed (6, 7, 10, 23) , for assessment of basal regional-renal perfusion, RBF, GFR, and tubular function, and repeated during supra-renal infusion of Ach (5 µg/kg/min) and sodium-nitroprusside (SNP, 6 nM/kg/min), to test endothelium-dependent andindependent responses, respectively. Blood pressure was monitored during each acute experiment using an intra-arterial vascular sheath in the carotid artery.
Following completion of all studies the pigs were euthanized with a lethal intravenous injection of Sleepawayâ (100mg/kg intravenous, Fort Dodge Laboratories, Inc, Fort Dodge, IA).
Kidneys were removed using a retroperitoneal incision, immediately shock-frozen in liquid nitrogen and stored at -80ºC, or preserved in formalin (6, 8, 9) . In vitro studies were then performed to characterize oxidative-stress, nitric oxide synthase (NOS) isoforms expression, and renal morphology. SOD activity was quantified in renal tissue and plasma using spectrophotometry. Superoxide anion was investigated in renal tissue using dihydroethidium (DHE) staining and fluorescence microscopy. Protein expression of the NAD(P)H-oxidase p47phox and p67phox subunits, CuZn-SOD, nitrotyrosine (as a footprint for peroxynitrite formation in vivo), and endothelial NOS (eNOS), were measured using Western blotting. In addition, using deparaffinized 5µm thick mid-hilar cross sections, renal morphology was evaluated using trichrome.
EBCT derived data analysis
Manually-traced regions-of-interest were selected in EBCT images in the aorta, renal cortex, medulla, and papilla, and their densities sampled. Time-density curves were generated and fitted with extended gamma-variate curve-fits, and the area enclosed under each segment of the curve and its first moment were calculated using the curve-fitting parameters(20). These were used to calculate renal regional perfusion (ml/minute/g tissue), intra-tubular fluid concentration (ITC), which is an index of segmental tubular fluid reabsorption and tubular function, single-kidney GFR, and RBF, using previously-validated methods (7, 9, 10, 20, 23) .
SOD assay
Total, manganese (Mn) and copper-zinc (CuZn) SOD isoforms activities were measured in renal tissue using a SOD Kit (R&D systems, Inc, Minneapolis, MN), as previously detailed (9) . For Mn SOD activity, 100 µL of potassium cyanide (KCN, 60mMol), which blocks CuZn SOD activity, was added to the mixture in parallel experiments.
In addition, SOD activity was also measured in plasma using the Cayman Chemical SOD Assay Kit (Cayman chemicals, Inc, Ann Arbor, MI), following vendor instructions. Briefly, blood anticoagulated with EDTA was centrifuged twice at 4˚C, and the supernatant was collected. The standards and samples were placed in a sample plate, and assayed in duplicate. Reaction was initiated by adding 20µl of diluted xanthine oxidase to all wells, and then the plate was incubated on a shaker at room temperature for 20 min. The absorbance of each standard and samples was read at 450 nm using a plate reader. The SOD activity was calculated from the linear regression of the standard curve substituting the linearized rate for each sample. One unit was defined as the amount of enzyme needed to exhibit 50% dismutation of the superoxide radical.
Western blotting: standard blotting protocols were followed, as previously described (6, 8) . Briefly, frozen renal tissue (including both cortex and medulla) was pulverized and Blotting Detection reagents, Amershan Biosciences), and then finally exposed to X-ray film (Kodak, NY), which was subsequently developed and intensities of the protein bands were determined using densitometry. Statistical Analysis: Results are mean ± SEM. Comparisons within groups were performed using paired student's t-test, and among groups using ANOVA, with the Bonferroni correction for multiple comparisons, followed by unpaired student's t-test. Statistical significance was accepted for p≤0.05.
Results
Lipid profile, MAP, and plasma creatinine were similarly and significantly elevated in all RVD groups compared to normal (Table 1) , while the degree of stenosis and PRA was not different among the groups (Table 1) (7, 8, 23) . Serum levels of vitamin C and E were significantly increased in the RVD+Vitamins animals (Table 1) .
Basal renal hemodynamics and function
Basal renal volume, RBF, GFR, and cortical perfusion were similarly and significantly decreased in all RVD animals compared to normal (Table 1) 
Response to Ach and sodium-nitroprusside
Infusion of Ach and SNP was not associated with a persistent change in blood pressure, as we have previously shown(7). In normal animals, Ach significantly increased RBF and GFR (to 747.9±92.7 and 102.7±7.4 mL/min, respectively, p≤0.003 for both), cortical and medullary perfusion (to 5.9±0.6 and 4.3±0.3 ml/min/g, respectively, p≤0.02 each). This response was blunted in RVD, in which Ach did not further increase RBF, GFR, or any regional perfusion compared to baseline (Figure 1a) . However, responses in treated animals were improved.
RVD+Tempol showed a strong trend for an increase in RBF (to 429.9.9±110.6 mL/min, p=0.063) and cortical perfusion (to 4.0±0.9 ml/min/g, p=0.07), and a substantial increase in GFR (to 65.4±16.6 mL/min, p=0.001) in response to Ach, while in RVD+Vitamins, Ach significantly increased single-kidney RBF (to 318.5±73.2 mL/min, p=0.01), GFR (to 48.3±16.9 mL/min, p=0.03), and cortical perfusion (to 4.8±0.6 ml/min/g, p=0.02). The increase of RBF responses to Ach was greater in RVD animals treated with chronic antioxidant supplementation compared to the other RVD groups (Figure 1a) . On the other hand, GFR responses were normalized in RVD+Vitamins, and were slightly greater in RVD+Tempol compared to RVD+Vitamins (Figure1b). Medullary perfusion remained unchanged among the experimental groups.
In response to SNP, normal animals showed a significant increase in RBF (to 728.1±45.9
ml/min, p=0.04), cortical, and medullary perfusion (to 5.2±0.4, and 3.6±0.39 mL/min/g tissue, respectively, p<0.04 for both), while in treated and untreated RVD animals these remained unchanged.
Redox Status, renal protein expression and morphology
Plasma endogenous SOD activity, as well as renal SOD activity (both total and its isoforms, Table 1 ) and protein expression (Figure 2a) , was similarly and significantly decreased in both treated and untreated RVD animals compared to normal. However, the increased protein expression of NAD(P)H-oxidase (p47phox and p67phox) observed in RVD and RVD+Tempol Moreover, RVD+Vitamins showed a decrease in trichrome staining (p<0.05 vs. RVD and RVD+Tempol), suggesting a significant decrease in renal fibrosis (Figure 3 ), although it remained greater than normal (p<0.001 vs. normal).
Discussion
This study demonstrates that both acute and chronic antioxidant intervention in experimental early RVD improves RBF and GFR responses to endothelium-dependent challenge. However, RBF response to Ach was greater in RVD animals chronically supplemented with antioxidants, and was accompanied by greater attenuation of superoxide production, possibly increased availability of NO, and a decrease in renal fibrosis. Thus, the impact of increased oxidative-stress on the hemodynamics and function of the stenotic kidney in RVD is amplified by chronic mechanisms that promote renal structural injury.
Oxygen radicals may lead to renal vasoconstriction and endothelial dysfunction, may enhance tubuloglomerular feedback, and modulate NO-dependent actions in the normal and sick kidney (17, 42, 53) . Augmented formation of ROS in common pathological situations such as atherosclerosis and hypertension is often mediated by activation of the renin-angiotensin system, and consequently NAD(P)-H oxidase (17, 34, 35) . Despite the fact that systemic PRA was not elevated in RVD animals in the current study, the intra-renal renin-angiotensin system was likely activated within the stenotic kidney. The signaling cascade for ROS generation through activation of the NAD(P)H oxidase by angiotensin II seems to involve a feed-forward mechanism that permits ongoing prolonged production of ROS (17) . ROS play an important role in many cardiovascular and renal diseases, and modulate several factors involved in vascular dysfunction, inflammation, cell proliferation, and tissue growth. Indeed, the ability to inhibit these pathogenic mechanisms using antioxidants and oxygen-radical scavengers(9, 22) provides further evidence for the importance of ROS in regulating these mechanisms.
We have previously shown that increased oxidative-stress and up-regulation of inflammatory and pro-fibrotic factors in RVD resulted in considerable structural injury, and was associated with marked impairment in renal hemodynamics, function, and responses to challenge (7, 8) . The current study extended our previous observations, and explored the contribution of increased oxidative-stress to short-and long-term regulation of renal hemodynamics in RVD. We interfered with the oxidative-stress pathway in RVD using either intra-renal infusion of the short-acting membrane-permeable SOD mimetic Tempol (43, 53) or chronic antioxidant intervention using long-acting vitamins C and E. These agents can improve endothelial function and increase NO availability by scavenging ROS or by reducing ROS production(29, 50). The superoxide anion has high affinity for NO, and their rapid reaction is 3 times faster than the reaction of superoxide with SODs and 10,000 times faster than its reaction with antioxidant enzymes (13, 14) . Tempol is a specific and potent short acting(48) superoxide radical scavenger, which does not act as a catalase mimetic or alter hydrogen peroxide concentration, and does not bind NO or produce superoxide anion(29). On the other hand, although vitamin C and E have lower affinity to ROS, they are long acting (3, 19) and can protect LDL from oxidation, reduce superoxide anion production and contribute to its scavenging, and modulate cytokines release and cell proliferation through inhibition of ROS-sensitive signaling pathways (26, 28, 50) . Therefore, the use of these different antioxidant strategies allows comparing the immediate and long-term effects of oxidative-stress in RVD.
The current study shows that basal renal hemodynamics and function remained attenuated in treated RVD compared to normal, and not different than in untreated RVD animals, likely because the severity of stenosis and renal atrophy were similar in all the RVD groups. In addition, ROS other than superoxide, such as singlet oxygen or hydroxyl radicals (18), might have not been modulated by the antioxidants used in this study (49) . Nevertheless, we observed improved RBF response to Ach in RVD+Tempol, resulting from decreased interaction with superoxide(43) and, consequently increased bioavailability of NO (44, 51) . A decrease in renal sympathetic nerve activity by Tempol may have also played a role in this renovascular improvement (45) . In addition, the vasodilatory effects of this active SOD analogue might have greater effects in the afferent than the efferent arteriole (44, 51) , which may give rise to the distinct effect on GFR observed in this and other studies (53) . Moreover, superoxide scavenging may also increase GFR by diminishing the tubulo-glomerular feedback mechanism (36, 54) . On the other hand, the improvement in renal hemodynamic response to the endothelium-dependent vasodilator Ach was greater in RVD+Vitamins. Several factors may help explain this differential response. In addition to potential scavenging of ROS, RVD+Vitamins showed normalization of NAD(P)H-oxidase expression, which remained elevated in RVD+Tempol. The NAD(P)Hoxidase is the major source of vascular and tissue superoxide anion, and its p47phox and p67phox subunits are located in renal endothelial, mesangial, vascular smooth muscle, and adventitial cells (15) . Furthermore, the substantial decrease in superoxide anion abundance in situ in the chronically-supplemented animals provides compelling support to decreased formation of this potent vasoconstrictor in RVD+Vitamins. The short-term nature of tempol infusion in this study is probably the reason that this effect was not observed in tempol-treated animals. Neither tempol nor vitamins modified endogenous SOD activity in this study, underscoring the pivotal contribution of the attenuation in ROS generation to the effects of chronic antioxidant intervention. Therefore, antioxidant vitamins may have resulted in a long-term effective decrease in ROS abundance, mainly by decreasing ROS formation in RVD.
Furthermore, vitamins C and E may have potentially increased NO bioavailability by upregulating eNOS (37, 50) an effect that was not observed with short-term tempol infusion. In addition to improving RBF response to Ach, suggestive evidence for increased NO bioavailability by chronic antioxidant intervention in the stenotic kidney was the decreased presence of nitrotyrosine residues, considered to be the footprint of peroxynitrite formation, which reflects interaction between superoxide and NO. Peroxynitrite is also a pro-oxidant cytotoxic metabolite capable of causing lipid peroxidation and cell damage (31) . Although peroxynitrite formation may decrease using chronic tempol administration(12), this was not observed after the acute infusion performed in the current study. Furthermore, increased local and systemic oxidative-stress can facilitate oxidation of LDL, a cytotoxic vasoconstrictor agent that promotes generation of ROS (2) 
